FY2025 Earnings Forecast for CVE:HIV Issued By Roth Capital

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities researchers at Roth Capital boosted their FY2025 earnings per share (EPS) estimates for HIVE Blockchain Technologies in a report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of ($0.54) for the year, up from their previous forecast of ($0.55). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.04) EPS, FY2027 earnings at $0.23 EPS and FY2028 earnings at ($0.10) EPS.

A number of other research firms also recently issued reports on HIV. Northland Capmk raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Finally, Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research report on Wednesday. Four equities research analysts have rated the stock with a strong buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.